Table of Contents

company-logo

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

Alpine Immune Sciences Dividend Announcement

• Alpine Immune Sciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Alpine Immune Sciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Alpine Immune Sciences Dividend History

Alpine Immune Sciences Dividend Yield

Alpine Immune Sciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Alpine Immune Sciences stock? Use our calculator to estimate your expected dividend yield:

Alpine Immune Sciences Financial Ratios

P/E ratio-112.94
PEG ratio66.63
P/B ratio12.50
ROE-14.86%
Payout ratio0.00%
Current ratio9.56
Quick ratio9.56
Cash Ratio1.02

Alpine Immune Sciences Dividend FAQ

Does Alpine Immune Sciences stock pay dividends?
Alpine Immune Sciences does not currently pay dividends to its shareholders.
Has Alpine Immune Sciences ever paid a dividend?
No, Alpine Immune Sciences has no a history of paying dividends to its shareholders. Alpine Immune Sciences is not known for its dividend payments.
Why doesn't Alpine Immune Sciences pay dividends?
There are several potential reasons why Alpine Immune Sciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Alpine Immune Sciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Alpine Immune Sciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Alpine Immune Sciences a dividend aristocrat?
Alpine Immune Sciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Alpine Immune Sciences a dividend king?
Alpine Immune Sciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Alpine Immune Sciences a dividend stock?
No, Alpine Immune Sciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Alpine Immune Sciences stocks?
To buy Alpine Immune Sciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Alpine Immune Sciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.